Catalyst Pharmaceuticals, Inc. (CPRX) reported adjusted diluted earnings of 53 cents per share for the fourth quarter of 2023, beating the Zacks Consensus Estimate of 48 cents. The company reported adjusted diluted earnings of 31 cents in the year-ago quarter.Total revenues amounted to $110.6 million in the reported quarter, which surpassed the Zacks Consensus Estimate of $106 million. Total product revenues surged 82% from the year-ago quarter’s $60.8 million. The top line primarily comprised product sales ...